Michael Bromberg, MD, PhD, Chief of the Section of Hematology at Temple University Hospital, discussed with HealthCentral two newly approved gene therapies for patients with the genetic blood disorder transfusion-dependent beta thalassemia.
800-TEMPLE-MED
Request Appointment
SEARCH TEMPLE HEALTH
Related News
Temple Health Experts Offer Insight on Jalen Hurts Blood Clot
Posted October 22, 2026Eagles quarterback Jalen Hurts was initially diagnosed with a superficial blood clot, and then deep vein thrombosis (DVT) and bilateral pulmonary emboli.
Read More